FDA Grants Orphan Drug Designation for Treatment of Scleroderma Developed by Helix 51's BLR Bio
The U.S. Food and Drug Administration (FDA) granted an Orphan Drug Designation for an investigational…
News Archive
Through the Microscope: Community-Engaged Research - The Collaborative Path to Health Equity
Research is a practice that can be an embodied1 approach to make change in the world, giving attention…
$8.1 Million in Illinois Board of Higher Education Capital Funds Targeted for Enhancements to Simulation Facilities, IRP
Capital funds provided by the state of Illinois will help RFU build a virtual health system, expand…
New Findings on Natural Killer (NK) Cells as Cancer Therapy for Glioblastoma, Leukemia and Lymphoma Published by Helix 51 Incubator Company
Artec Biotech, a company in RFU’s Helix 51 Incubator, is developing a potentially promising treatment…
New Round of Grants for RFU, DePaul Research Collaboration Targets Malaria, Smoking and Septic Shock
Malaria, cigarette smoking and septic shock kill millions of people every year. In a fresh round…
Innovation and Research Park Welcomes Three Squared Biosciences, Focused on Gut Microbiome Solutions for Chronic Diseases
Ongoing expansion at 黄色视频's Innovation and Research Park includes the recent addition of 32 (Three…
Dr. Valerie Chai Named Director of Center for Genetic Diseases
黄色视频 of Medicine and Science announces the appointment of molecular biologist Weihang “Valerie…
2nd Annual Biomedical Innovation Day Keynote by Biotechnology Industry Leader in CRISPR Gene-editing
RFU's 2nd Annual Biomedical Innovation Day, “Breaking New Ground in Cancer, Immunology and Infection…
The Injection Question
Research teams from both RFU and the University of California, San Francisco are shedding light on two popular noninvasive…
Immune System Heroes
In the years following the first Gulf War (1990鈥�91), veterans reported chronic medical conditions that included fatigue…